Resultat av tuberkulosebehandling i Norge 1995

摘要

SAMMENDRAGI tillegg til insidens og mortalitet, har andelen pasienter som fullf?rer tuberkulosebehandlingen (?helbredelsesrate?) nylig blitt anbefalt av IUATLD og WHO som en indikator for vurdering av tuberkulosekontrollen.I denne studien ble resultatet av tuberkulosebehandlingen vurdert hos alle pasienter med dyrkningsbekreftetlungetuberkulose meldt til Det sentrale tuberkuloseregister i 1995. Av 101 pasienter fullf?rte 77 behandlingen(?helbredelsesrate? 76%), 9 forsvant, 14 d?de og én fortsatte ? v?re smittef?rende. De fleste (7 av 9)som forsvant var f?dt utenfor Norge, mens de fleste (13 av 14) som d?de var f?dt i Norge.Helbredelsesraten i Norge er langt d?rligere enn WHOs anbefalinger (85% helbredelsesrate) og resultateneoppn?dd i enkelte andre land som Nederland. Vurdering av behandlingsresultat er en viktig del avtuberkuloseoverv?kningen. Tiltak b?r iverksettes for ? redusere mortaliteten og andelen pasienter somforsvinner f?r avsluttet behandling.Heldal E.?Results of tuberculosis treatment in Norway 1995. Nor J Epidemiol 1997; 7 (2): 231-233.?ENGLISH SUMMARYIn addition to incidence and mortality the proportion of patients who complete tuberculosis treatment (curerate) has recently been recommended by the IUATLD and WHO as an indicator in assessing tuberculosiscontrol. In the present study the result of tuberculosis treatment was assessed in all patients with cultureconfirmed pulmonary tuberculosis notified to the National Tuberculosis Register in 1995. Out of 101patients 77 completed treatment (cure rate 76%), 9 disappeared, 14 died and one continued to be contagious(failure case). Most of those who disappeared (7 out of 9) were born outside Norway, while most of thosewho died (13 out of 14) were born in Norway.The cure rate in Norway was far below the level of 85% recommended by WHO, and achieved incountries like the Netherlands. The assessment of treatment result is an important component of tuberculosissurveillance. Action should be taken to reduce mortality and the proportion of patients who disappear fromtreatment.INNLEDNING